Literature DB >> 11232946

Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma.

M Deutsch1, K Gerszten, W D Bloomer, E Avisar.   

Abstract

Twelve women treated with radiotherapy with or without chemotherapy for Hodgkin's disease (11 patients) and non-Hodgkin's lymphoma (1 patient) and in whom breast cancer subsequently developed 10 to 29 years later were treated with lumpectomy and breast irradiation. 5,000 cGy/25-30 fractions to the whole breast and 900 cGy to 1.000 cGy/5 boost to the operative area. Six also received adjuvant chemotherapy for breast cancer. Breast irradiation was well tolerated without any unusual acute or chronic sequelae. All women had a good to excellent cosmetic result. Ten women are alive and well 1 to 174 months (median: 46) from completion of breast irradiation. Two women died with distant metastasis but without local recurrence. Breast conservation therapy with radiotherapy is not contraindicated in the woman who has previously been treated with radiotherapy for Hodgkin's disease or lymphoma.

Entities:  

Mesh:

Year:  2001        PMID: 11232946     DOI: 10.1097/00000421-200102000-00005

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  6 in total

1.  A rare complication resulting in a rare disease: radiation-induced male breast cancer.

Authors:  Jamila Alazhri; Constantine Saclarides; Eli Avisar
Journal:  BMJ Case Rep       Date:  2016-04-15

2.  A new option for early breast cancer patients previously irradiated for Hodgkin's disease: intraoperative radiotherapy with electrons (ELIOT).

Authors:  Mattia Intra; Oreste Gentilini; Paolo Veronesi; Mario Ciocca; Alberto Luini; Roberta Lazzari; Javier Soteldo; Gabriel Farante; Roberto Orecchia; Umberto Veronesi
Journal:  Breast Cancer Res       Date:  2005-08-16       Impact factor: 6.466

3.  Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy.

Authors:  Uta Kraus-Tiefenbacher; Lelia Bauer; Antonella Scheda; Carola Schoeber; Joerg Schaefer; Volker Steil; Frederik Wenz
Journal:  BMC Cancer       Date:  2007-09-14       Impact factor: 4.430

4.  Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: case-control analysis.

Authors:  Mohamed A Alm El-Din; Kevin S Hughes; Rita A Raad; Saveli I Goldberg; Alan C Aisenberg; Andrzej Niemierko; Alphonse G Taghian
Journal:  Radiat Oncol       Date:  2009-06-30       Impact factor: 3.481

Review 5.  Medical factors influencing decision making regarding radiation therapy for breast cancer.

Authors:  Christina A Dilaveri; Nicole P Sandhu; Lonzetta Neal; Michelle A Neben-Wittich; Tina J Hieken; Maire Brid Mac Bride; Dietlind L Wahner-Roedler; Karthik Ghosh
Journal:  Int J Womens Health       Date:  2014-11-19

6.  Secondary breast cancer after Hodgkin lymphoma: a case report and literature review.

Authors:  Joaira Bakkach; Mohamed Mansouri; Ali Loudiyi; Naima Ghailani Nourouti; Amina Barakat; Mohcine Bennani Mechita
Journal:  Ecancermedicalscience       Date:  2018-02-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.